Willow Non Current Liabilities Total from 2010 to 2025
| WLLW Stock | CAD 0.01 0.01 33.33% |
Non Current Liabilities Total | First Reported 2000-09-30 | Previous Quarter 1.2 M | Current Value 1 M | Quarterly Volatility 4.5 M |
Check Willow Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Willow Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 171.5 K, Selling And Marketing Expenses of 20.8 K or Other Operating Expenses of 17.7 M, as well as many indicators such as Price To Sales Ratio of 11.58, Dividend Yield of 0.0 or PTB Ratio of 4.37. Willow financial statements analysis is a perfect complement when working with Willow Biosciences Valuation or Volatility modules.
Willow | Non Current Liabilities Total |
Other Information on Investing in Willow Stock
Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.